GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ludwig Enterprises Inc (OTCPK:LUDG) » Definitions » Current Ratio

Ludwig Enterprises (Ludwig Enterprises) Current Ratio : 0.07 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Ludwig Enterprises Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Ludwig Enterprises's current ratio for the quarter that ended in Dec. 2023 was 0.07.

Ludwig Enterprises has a current ratio of 0.07. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Ludwig Enterprises has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Ludwig Enterprises's Current Ratio or its related term are showing as below:

LUDG' s Current Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.23   Max: 0.38
Current: 0.07

During the past 2 years, Ludwig Enterprises's highest Current Ratio was 0.38. The lowest was 0.07. And the median was 0.23.

LUDG's Current Ratio is ranked worse than
98.28% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 2.685 vs LUDG: 0.07

Ludwig Enterprises Current Ratio Historical Data

The historical data trend for Ludwig Enterprises's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ludwig Enterprises Current Ratio Chart

Ludwig Enterprises Annual Data
Trend Dec22 Dec23
Current Ratio
0.38 0.07

Ludwig Enterprises Quarterly Data
Sep22 Dec22 Sep23 Dec23
Current Ratio - 0.38 0.01 0.07

Competitive Comparison of Ludwig Enterprises's Current Ratio

For the Medical Devices subindustry, Ludwig Enterprises's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ludwig Enterprises's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ludwig Enterprises's Current Ratio distribution charts can be found below:

* The bar in red indicates where Ludwig Enterprises's Current Ratio falls into.



Ludwig Enterprises Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Ludwig Enterprises's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=0.112/1.574
=0.07

Ludwig Enterprises's Current Ratio for the quarter that ended in Dec. 2023 is calculated as

Current Ratio (Q: Dec. 2023 )=Total Current Assets (Q: Dec. 2023 )/Total Current Liabilities (Q: Dec. 2023 )
=0.112/1.574
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ludwig Enterprises  (OTCPK:LUDG) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Ludwig Enterprises Current Ratio Related Terms

Thank you for viewing the detailed overview of Ludwig Enterprises's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ludwig Enterprises (Ludwig Enterprises) Business Description

Traded in Other Exchanges
N/A
Address
1749 VICTORIAN AVENUE, Suite C-350, Sparks, NV, USA, 89431
Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.